Studie přijímající pacienty = ; Probíhající studie = ; Ukončená studie = ; Financováno členem konsorcia IRDiRC = ; Člen ERN =

Národní klinické studie

KANADA

Ontario
TORONTO

Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)

The Hospital for Sick Children and University of Toronto

Department of Ophthalmology and Vision Science

Více informací

FRANCIE

ILE-DE-FRANCE
PARIS

Traitement adjuvant dans les rétinoblastomes unilatéraux étendus énucléés d'emblée (Phase II)

CLCC Institut Curie

Département d'Oncologie pédiatrique, adolescents et jeunes adultes

Více informací

NIZOZEMSKO

Noord-Holland
AMSTERDAM

The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)

Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Afdeling Maag-Darm-Leveroncologie

Více informací

BELGIE

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

STEP: Programme d'extension à long terme du Sorafénib - BE

Cliniques universitaires Saint-Luc - UCLouvain

Pneumologie_Oncologie thoracique

Více informací

ITÁLIE

LAZIO
ROMA

Studio in aperto, a braccio singolo, di fase 1/2 che valuta la sicurezza e l'efficacia di Ponatinib per il trattamento delle leucemie ricorrenti o refrattarie o dei tumori solidi in pazienti pediatrici

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Oncoematologia

Více informací